Table III.
Effect on serum level of tumor marker | |||
---|---|---|---|
|
|||
Case | Adverse effect | 1 month post treatment | 6 months post treatment |
1 | Mild liver dysfunction | Elevated | Decreased |
2 | None | Decreased | - |
3 | None | Elevated | Elevated |
4 | None | Decreased | Elevated |
5 | None | Elevated | - |
6 | None | Decreased | Decreased |
7 | None | Elevated | - |
8 | Mild liver dysfunction | Decreased | Elevated |
9 | Mild liver dysfunction | Decreased | Decreased |
10 | None | Decreased | - |
11 | None | Decreased | Decreased |
12 | Mild liver and renal dysfunction | Decreased | Elevated |
-, not evaluable.